- Global Pharma News & Resources

Rising sepsis awareness globally will boost the sepsis diagnostics market, forecast to touch US$ 725 Million by 2026 at a CAGR of 8%

Noida, Uttar Pradesh, India, February 19 2021 (Wiredrelease) Report Ocean Pvt Ltd –:Sepsis is a severe complication arising due to a compromised immune system that leads people to become susceptible to viral, bacterial, parasitic, fungal, or other infections. The growing burden of infectious diseases, the rise in public-private funding for target research activities, the increasing number of sepsis incidences, and growing government initiatives for creating sepsis awareness are expected to raise the demand for sepsis diagnostic products over the forecast period. Driven by these promising developments, the Global Sepsis Diagnostics Market is estimated to see healthy growth, pegged at a CAGR of ~8% during the forecast period 2020-2026.


Hospitals lead the massive demand for sepsis diagnostics practice throughout the forecast period

Hospitals segment are creating lucrative opportunities for the demand in the market due to the high prevalence of sepsis and a large number of fatalities caused by the illness, and in-house hospital laboratories carried a large number of blood culture tests to identify BSIs (caused by bacteria, fungi/yeast, or viruses). Such factors are determined to create revenue opportunities for sepsis diagnostics worldwide in 2019 and beyond the forecast period.

Sector Overview

The introduction of technologically innovative medical examination solutions for the life-threatening disease condition and growing regulatory approval are expected to ease sepsis diagnostics’ consumption growth during the study period. In May 2018, T2 Biosystems, Inc., a US-based emerging medical examination solutions company, received the U.S. FDA approval for its T2Bacteria Panel, intended to detect specific sepsis-causing bacterial pathogens in human whole blood specimens.

In April 2019, the Scottish Government partnered with Sepsis Research (originally called FEAT – The Fiona Elizabeth Agnew Trust) to introduced a Scotland-wide movement to spread public awareness related to sepsis’s signs and symptoms. Such initiatives are focused on raising public awareness about the disease condition and the need to take diagnostics at the earliest to minimize the risk, leading to the demand for rapid medical examination solutions and further supporting market growth.

Segmentation Overview of the Global Sepsis Diagnostics Market

The global sepsis diagnostics market has been segmented into Product, Technology, Pathogen, Testing Type, and End-User. These major market segments are further categorized into various sub-segments to study the market in detail.

By Product Outlook

Instruments (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry)

Blood Culture Media (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry)

Assay Kits and Reagents (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry)

Software (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry)

By Technology Outlook (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry)

By Pathogen Outlook

Bacterial Sepsis (Gram-Positive Bacteria, Gram-Negative Bacteria)
Fungal Sepsis

By Testing Type Outlook (Laboratory Testing, PoC Testing)

By End-User (Hospitals, Pathology & Reference Laboratories, Research Laboratories & Academic Institutes)

Key Players Insights

The crucial global sepsis diagnostics market players include BioMérieux SA, Thermo Fisher Scientific, Inc., T2 Biosystems, Inc., Nanosphere, Inc., Cepheid, Roche Diagnostics Limited, Abbott Laboratories, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, and Bruker Corporation, among others. By analyzing competitor benchmarking and various market developments between 2016 and 2019, companies adopted partnerships, agreements, product launches, and acquisitions to strengthen their product portfolios and market position globally in the market. The product launches were the most widely adopted growth strategies adopted in the past few years in the global sepsis diagnostics market.


This content has been published by Report Ocean Pvt Ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 19-Feb-2021